Gagomers are novel particles (neither liposomes nor microspheres/ nanospheres) composed of hyaluronan shell which is crossed linked to phospholipids and can be generated either as micro or nano particles. The research team at Tel Aviv University has demonstrated that: (1) Gagomers efficiently encapsulate fibrillar Insulin (2) gagomers are protecting the insulin in the GIT (3) Due to the hyaluronan shell Gagomers are targeting the Insulin to intestinal mucosa and show muco-adhesive properties in the intestine and (4) In vivo studies with diabetic (STZ-induced) mice, under conditions that mimic human eating habits, demonstrated an anti-Glycemic effect reducing blood glucose levels from diabetic to normal.
Project ID : 10-2008-113
The Technology
Gagomers are novel particles (neither liposomes nor microspheres/ nanospheres) composed of hyaluronan shell which is crossed linked to phospholipids and can be generated either as micro or nano particles. The research team at Tel Aviv University has demonstrated that: (1) Gagomers efficiently encapsulate fibrillar Insulin (2) gagomers are protecting the insulin in the GIT (3) Due to the hyaluronan shell Gagomers are targeting the Insulin to intestinal mucosa and show muco-adhesive properties in the intestine and (4) In vivo studies with diabetic (STZ-induced) mice, under conditions that mimic human eating habits, demonstrated an anti-Glycemic effect reducing blood glucose levels from diabetic to normal.
Potential Application
Oral delivery of mid to long-acting Insulin
Stage of Development
Patents
PCT patent application (WO 2009/108554 A2)
Supporting Publications
Dekel Y, Glucksam Y and Margalit R, Novel fibrillar insulin formulations for oral administration: Formulation and in vivo studies in diabetic mice. Journal of Controlled Release 2012, 143: 128–135.
Project manager
Adi Elkeles
BD Manager
Project researchers
Rimona Margalit
T.A.U Tel Aviv University, Life Sciences
The Department of Biochemistry and Molecular Biology
Yaron Dekel
T.A.U Tel Aviv University, Life Sciences
The Department of Biochemistry and Molecular Biology
Ramot is Tel Aviv University's (TAU) technology transfer company and its liaison to industry, bringing promising scientific discoveries made at the university to industry's attention. The company provides the legal and commercial frameworks for inventions made by TAU faculty, students and researchers, protecting discoveries with patents and working jointly with industry to bring scientific innovations to the market.
Create your free account to connect with RAMOT at Tel Aviv University Ltd. and thousands of other innovative organizations and professionals worldwide
Send a request for information
to RAMOT at Tel Aviv University Ltd.
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support
Innoget is a simple and secure way to make trustworthy contacts, initiate projects and share knowledge about technologies with guaranteed protection of Intellectual Property and confidentiality
TRUSTED BY WORLD’S LEADING ORGANIZATIONS
Enter your details below to access your account.
